Advertisement
Advertisement
U.S. markets open in 9 hours 21 minutes
Advertisement
Advertisement
Advertisement
Advertisement

McKesson Corporation (MCK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
354.77+7.39 (+2.13%)
At close: 04:03PM EDT
355.00 +0.23 (+0.06%)
After hours: 07:37PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close347.38
Open350.00
Bid349.23 x 1200
Ask355.80 x 1100
Day's Range349.57 - 358.64
52 Week Range193.89 - 358.64
Volume1,282,663
Avg. Volume1,090,469
Market Cap50.991B
Beta (5Y Monthly)0.63
PE Ratio (TTM)37.66
EPS (TTM)9.42
Earnings DateOct 31, 2022 - Nov 04, 2022
Forward Dividend & Yield2.16 (0.62%)
Ex-Dividend DateAug 31, 2022
1y Target Est377.92
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-24% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MCK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • McKesson Corporation
    Analyst Report: McKesson CorporationMcKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
    Rating
    Fair Value
    Economic Moat
    12 hours agoMorningstar
View more
Advertisement
Advertisement